How to Use Publications to Identify a KOL’s Key Research Interests
How to Use Publications to Identify a KOL’s Key Research Interests
There are many ways to identify Key Opinion Leaders (KOLs) but to engage a KOL, one should understand that researcher’s areas of scientific interest
The Crucial Role of Conference Papers in an Era of Hyperspecialization
Conference literature can be an important way to bridge the gap between different scientific specialties — and to broaden the general knowledge base of specialists READ MORE
What data tips the scale for a “go” decision among care providers?
At a high level, providers are concerned with two primary considerations: cost and quality. READ MORE
How to Optimize Your Medical Affairs Efforts: Share of Scientific Voice
Share of Scientific Voice is a relative measure of how frequently your drug or other therapeutic is mentioned in the biomedical discourse. There are no hard and fast rules for defining the domain but it should be broad enough to include treatment options a physician would consider. READ MORE
What data tips the scale for a “go” decision among care providers?
At a high level, providers are concerned with two primary considerations: cost and quality.
READ MORE
PRESS: Pharmaspectra’s Christian Schweiger in this Month’s Pharmafield
Pharmaspectra’s Christian Schweiger shares how MSLs and Sales can work closer when engaging with experts and building out communication messages
READ MORE
The Crucial Role of Conference Papers in an Era of Hyperspecialization
Conference literature can be an important way to bridge the gap between different scientific specialties — and to broaden the general knowledge base of specialists
READ MORE
Pharmaspectra Appoints New CEO to Drive Growth of Its Unique Data and Insight Tools
New CEO, Jez Moulding, formerly of Sanofi and UDG/Ashfield Healthcare
READ MORE
Anti-Inflammatory Drugs May Have Role in Mitigating the Risk of Dementia
Inflammation correlates with neurodegeneration but until recently, the association has been assumed to be a consequence of neurodegeneration and not a causal factor.
READ MORE
Increasing the Value of Field Medical
For MSLs, saving on the time required to prepare for each scientific engagement and being able to validate efforts, will be essential. For leadership and management, the math can be exceptionally clear.
READ MORE
Medical Affairs & the Shift from Quantity to Quality in Healthcare
With its ability to help measure, collect, and interpret data for all stakeholders, Medical Affairs will play an increasingly important role.
READ MORE
How to Optimize Your Medical Affairs Efforts: Share of Scientific Voice
Share of Scientific Voice is a relative measure of how frequently your drug or other therapeutic is mentioned in the biomedical discourse. There are no hard and fast rules for defining the domain but it should be broad enough to include treatment options a physician would consider.
READ MORE
Medical Affairs as a Strategic Advantage
From Headquarters to Field Medical teams, accessing current data and metrics that matter is allowing Medical Affairs to make data-based decisions more efficiently and more accurately than ever before
READ MORE
Key Factors for Medical Affairs to Define and Communicate
When you’re looking to position therapeutics against alternatives, it pays to know what matters most to stakeholders
READ MORE
